Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Deheng Nie"'
Autor:
LiLi Xu, Mengmeng Wang, Siqi Zhang, Wenjia Liu, Mengge Zheng, Deheng Nie, Huimin Tian, Zhenbang Feng, Fujun Han
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 10 (2022)
Background The addition of cetuximab significantly increased the antitumor effect of programmed cell death protein 1 (PD-1) inhibitors in recurrent or metastatic head and neck squamous cell carcinoma (HNSCC). However, preliminary analyses suggested t
Externí odkaz:
https://doaj.org/article/78f5de47d31641ca96b81f2a2bec6b71
Publikováno v:
Current Medical Science. 42:118-128
Objective An understanding of the leading causes of death in patients with head and neck squamous cell carcinoma (HNSCC) would be helpful to inform doctors, patients, and healthcare providers on disease management. This study aimed to comprehensively
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::82755b8e3b5f37e0d1148ca10bdf42ec
https://doi.org/10.1007/s11596-021-2427-x
https://doi.org/10.1007/s11596-021-2427-x
Autor:
Siqi Zhang, Mengge Zheng, Deheng Nie, Lili Xu, Huimin Tian, Mengmeng Wang, Wenjia Liu, Zhenbang Feng, Fujun Han
Publikováno v:
Journal for immunotherapy of cancer. 10(10)
BackgroundThe addition of cetuximab significantly increased the antitumor effect of programmed cell death protein 1 (PD-1) inhibitors in recurrent or metastatic head and neck squamous cell carcinoma (HNSCC). However, preliminary analyses suggested th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c8efb46782a72a78a92b4b422a25e0a
https://pubmed.ncbi.nlm.nih.gov/36253001
https://pubmed.ncbi.nlm.nih.gov/36253001
Autor:
Fujun Han, Wenhui Liu, Zhenbang Feng, Xin Wang, Meiting Sun, Deheng Nie, Fengli Pei, Zonghan Wang
Publikováno v:
Radiotherapy and Oncology. 158:13-20
To assess the survival benefits associated with epidermal growth factor receptor (EGFR) inhibitors in head and neck squamous cell carcinoma (HNSCC) according to the primary site.A systematic review and meta-analysis were conducted for randomized phas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1594b6c51273e63356b70e0035a06f14
https://doi.org/10.1016/j.radonc.2021.02.001
https://doi.org/10.1016/j.radonc.2021.02.001
Autor:
Fujun Han, Siqi Zhang, Mengge Zheng, Deheng Nie, Huimin Tian, Wenjia Liu, Fengli Pei, Wenhui Liu
Background: The erythropoietin-producing human hepatocellular receptor A3 (EPHA3), which was identified as a tumor antigen targeted by a lytic T-cell response in melanoma patients, is relatively tumor specific. Moreover, EPHA3 is frequently mutated i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce97ca67596356ebef0512f0069e0045
https://doi.org/10.21203/rs.3.rs-1308057/v1
https://doi.org/10.21203/rs.3.rs-1308057/v1
Publikováno v:
Oral Oncology. 114:105142
This study aimed to evaluate the difference in tumor mutation burden (TMB) between oral cavity squamous cell carcinoma (OCSCC) and larynx squamous cell carcinoma (LSCC).Patients with OCSCC or LSCC were identified from datasets within The Cancer Genom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3761cad3fa235f830c8eb6b5984cdc6
https://doi.org/10.1016/j.oraloncology.2020.105142
https://doi.org/10.1016/j.oraloncology.2020.105142